Risk factors for subsequent recurrence after surgical treatment of recurrent pleomorphic adenoma of the parotid gland.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 33275822.
- Also identified by DOI 10.1002/hed.26570.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recurrent pleomorphic adenoma (PA) can be a lifelong disease, and rates of subsequent recurrence are high. Patients between 2000 and 2015 were identified. Primary outcome was subsequent recurrence after surgical salvage. Twenty-seven of 84 patients developed a subsequent recurrence. Risk factors for subsequent recurrence included a higher number of previous recurrences (P < .01), worse preoperative facial nerve function (P < .01), and deep parotid lesion(s) (P < .01). Interval since last surgery was protective (P < .01), specifically >10 years since last surgery (P < .01). For patients with a >10-year interval since their last surgery, the subsequent recurrence-free rate at 10 years follow-up was 80.2% vs 31.8%. For patients presenting with a >10-year interval since their last surgery, subsequent recurrence rates are low, which may allow for as needed surveillance recommendations. For patients presenting with recurrent PA and ≤10 years since their last surgery, a closer surveillance is warranted.
Medical subject headings
- Adenoma, Pleomorphic
- Parotid Neoplasms